log (agonist) vs. response variable slope four parameter curve fit in graphpad prism 5.0 software Search Results


bio lc  (Agilent technologies)
95
Agilent technologies bio lc
Bio Lc, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/Bio+LC/custom%40g7131c%4037906637
Average 95 stars, based on 1 article reviews
bio lc - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
compusyn software  (ComboSyn Inc)
90
ComboSyn Inc compusyn software
Compusyn Software, supplied by ComboSyn Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/compusyn+software/pmc05691578-52-11-13
Average 90 stars, based on 1 article reviews
compusyn software - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rapid panotic  (Laborclin BR)
90
Laborclin BR rapid panotic
Rapid Panotic, supplied by Laborclin BR, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/rapid+panotic/pmc10777850-501-9-11
Average 90 stars, based on 1 article reviews
rapid panotic - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
washed  (Valiant Co Ltd)
96
Valiant Co Ltd washed
Washed, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/Washed/custom%400855876%4035830486
Average 96 stars, based on 1 article reviews
washed - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
agarose  (Valiant Co Ltd)
96
Valiant Co Ltd agarose
Agarose, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/Agarose/custom%400219398310%4035830486
Average 96 stars, based on 1 article reviews
agarose - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
discoverrx pathhunter ® assay kit  (DiscoverX corporation)
90
DiscoverX corporation discoverrx pathhunter ® assay kit
Discoverrx Pathhunter ® Assay Kit, supplied by DiscoverX corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/discoverrx+pathhunter+++assay+kit/pmc10352325-228-33-38
Average 90 stars, based on 1 article reviews
discoverrx pathhunter ® assay kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
zetaview nanoparticle tracker  (Particle Metrix)
90
Particle Metrix zetaview nanoparticle tracker
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> <t>Nanoparticle</t> Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
Zetaview Nanoparticle Tracker, supplied by Particle Metrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/nanoparticle+tracking+analysis+zetaview/pmc06780992-234-6-9
Average 90 stars, based on 1 article reviews
zetaview nanoparticle tracker - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
the corresponding zetaview software (8.03.04.01)  (Particle Metrix)
90
Particle Metrix the corresponding zetaview software (8.03.04.01)
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
The Corresponding Zetaview Software (8.03.04.01), supplied by Particle Metrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/its+corresponding+software++zetaview+8+02+28+/pmc06780992-234-17-9
Average 90 stars, based on 1 article reviews
the corresponding zetaview software (8.03.04.01) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ht7800  (Hitachi Ltd)
99
Hitachi Ltd ht7800
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
Ht7800, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/HT7800/custom%40ht7800%4037883475
Average 99 stars, based on 1 article reviews
ht7800 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
tmb peroxidase substrate 5120-0083  (SeraCare Life Sciences)
90
SeraCare Life Sciences tmb peroxidase substrate 5120-0083
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
Tmb Peroxidase Substrate 5120 0083, supplied by SeraCare Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/tmb+peroxidase+substrate+5120+0047/pmc07399188__mmc1-63-8-11
Average 90 stars, based on 1 article reviews
tmb peroxidase substrate 5120-0083 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
spectramax i3x  (Danaher Inc)
99
Danaher Inc spectramax i3x
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
Spectramax I3x, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/SpectraMax+i3x/custom%40md-223%4032744131
Average 99 stars, based on 1 article reviews
spectramax i3x - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
mpxv a35 protein  (Sino Biological)
93
Sino Biological mpxv a35 protein
Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using <t>ZetaView</t> Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7
Mpxv A35 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log+(agonist)+vs%2E+response+variable+slope+four+parameter+curve+fit+in+graphpad+prism+5%2E0+software/Monkeypox+Virus+(MPXV)+Protein+A35/pmc10213010__41421_2023_556_MOESM1_ESM-14-35-38
Average 93 stars, based on 1 article reviews
mpxv a35 protein - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using ZetaView Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7

Journal: British Journal of Pharmacology

Article Title: A novel and potent brain penetrant inhibitor of extracellular vesicle release

doi: 10.1111/bph.14789

Figure Lengend Snippet: Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using ZetaView Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7

Article Snippet: Extra cellular vesicles were quantified using ZetaView Nanoparticle tracker (Particle Metrix GmBH, Meerbusch, Germany) and the corresponding Zetaview software (8.03.04.01). pEC 50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] vs. response using GraphPad Prism 7.

Techniques: Inhibition, Incubation, Concentration Assay

Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using ZetaView Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7

Journal: British Journal of Pharmacology

Article Title: A novel and potent brain penetrant inhibitor of extracellular vesicle release

doi: 10.1111/bph.14789

Figure Lengend Snippet: Inhibition of EV secretion by PDDC and 5 in glial cells. Primary astrocytes were treated in parallel incubations with PDDC, 5, or cambinol in the 0.03–30 μM range as indicated; DMSO (0.02%) was used as vehicle control (set as 100% on y‐axis). Media was collected after 2‐hr incubation and centrifuged at 2,700 g for 15 min at 4°C. Supernatant was collected and the number of extracellular vesicles (EVs) was quantified using ZetaView Nanoparticle Tracker. The data points correspond to per cent inhibition of EV release (±SEM) over a concentration range for each compound; 100% release corresponds to 4.87 × 107 ± 0.098 EVs. Results are the average of three or four independent assays. Each independent assay was the average of three replicates. pEC50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] against response, using GraphPad Prism 7

Article Snippet: Extra cellular vesicles were quantified using ZetaView Nanoparticle tracker (Particle Metrix GmBH, Meerbusch, Germany) and the corresponding Zetaview software (8.03.04.01). pEC 50 values and corresponding 95% confidence asymmetrical intervals, CI (95%), were obtained from a non‐linear fit of log [inhibitor] vs. response using GraphPad Prism 7.

Techniques: Inhibition, Incubation, Concentration Assay